BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SIRT1
,
G-protein-coupled receptor binding
,
Lung cancer
,
Neuron
,
Holistic medicine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
darapladib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferropto…
Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a ther…
The selective lipoprotein-associated phospholipase A2 inhibitor darapladib triggers irreversible act…
Active site competition is the mechanism for the inhibition of lipoprotein-associated phospholipase …
Lp-PLA2 Selective Inhibitor (Darapladib) Effect In Lowering The Expression Level Of IL-1B And IL-6 I…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Darapladib China PK
Study to Evaluate Darapladib in Moderately Hepatically Impaired Subjects
A Study With Darapladib to Collect Tolerability Information
Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ